Development and validation of a model for staging hepatic fibrosis for chronic hepatitis B patients with E antigen-positive

被引:2
作者
Wang, Hong [1 ]
Zhou, Ying [1 ]
Yan, Rong [1 ]
Ru, Guo Qing [2 ]
Yu, Li Li [2 ]
Wang, Ming Shan [1 ]
Chen, Mei Juan [1 ]
机构
[1] Hangzhou Med Coll, Peoples Hosp, Zhejiang Prov Peoples Hosp, Dept Infect Dis, Hangzhou, Zhejiang, Peoples R China
[2] Hangzhou Med Coll, Peoples Hosp, Zhejiang Prov Peoples Hosp, Dept Pathol, Hangzhou, Zhejiang, Peoples R China
关键词
E antigen positive; hepatitis B virus; liver fibrosis; liver biopsy; non-invasive fibrosis marker; SIMPLE NONINVASIVE INDEX; SURFACE-ANTIGEN; LIVER FIBROSIS; NATURAL-HISTORY; PREDICT; FIB-4; INFECTION; STANDARD; BIOPSY; APRI;
D O I
10.18632/oncotarget.22003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Interest is growing in the use of non-invasive techniques for complementing liver biopsy for liver fibrosis assessment. We aimed to prospectively evaluate liver histology in chronic hepatitis B (CHB) patients with e-antigen positivity, and develop and validate a novel scoring system-e-antigen-positive CHB liver fibrosis (EPLF) score-for noninvasively predicting the fibrosis stages. Methods: We identified the baseline variables associated with fibrosis stage (MATAVIR score, F0-F4) in 212 CHB patients with e-antigen positivity. These significant variables were used to develop the EPLF scoring system. The EPLF score equation was developed based on the prediction of fibrosis stages via multivariate ordered logistic regression analysis. The diagnostic powers of the EPLF score and several non-invasive markers were assessed through an area under the receiver operating characteristic curve (AUROC) analyses. This EPLF score model was validated in another set of 208 similar patients. Results: The natural logarithms of serum albumin, HBeAg, and HBsAg levels were selected as significant independent variables for the EPLF score equation. The EPLF score had good diagnostic power (AUROC, 0.72-0.90, p< 0.001) and good diagnostic accuracy (72-85%), with a high positive predictive value (80.8-92.8%) for each fibrosis stage in the test group. Similar results were observed in the validation group (AUROC, 0.73-0.89, p< 0.001). The EPLF score exhibited a strong correlation with fibrosis stage (r= 0.67, p< 0.001), and was the preferable non-invasive marker for staging liver fibrosis. Conclusion: In e-antigen-positive patients with CHB, the EPLF score could serve as a potential non-invasive marker of liver fibrosis stage.
引用
收藏
页码:98812 / 98822
页数:11
相关论文
共 30 条
[1]   An algorithm for the grading of activity in chronic hepatitis C [J].
Bedossa, P ;
Poynard, T .
HEPATOLOGY, 1996, 24 (02) :289-293
[2]   A novel panel of blood markers to assess the degree of liver fibrosis [J].
Calès, P ;
Oberti, F ;
Michalak, S ;
Hubert-Fouchard, I ;
Rousselet, MC ;
Konat, A ;
Gallois, Y ;
Ternisien, C ;
Chevailler, A ;
Lunel, F .
HEPATOLOGY, 2005, 42 (06) :1373-1381
[3]   Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis B-related fibrosis: a leading meta-analysis [J].
Jin, Wenwen ;
Lin, Zhonghua ;
Xin, Yongning ;
Jiang, Xiangjun ;
Dong, Quanjiang ;
Xuan, Shiying .
BMC GASTROENTEROLOGY, 2012, 12
[4]   Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients [J].
Kim, W. Ray ;
Berge, Thomas ;
Asselah, Tarik ;
Flisiak, Robert ;
Fung, Scott ;
Gordon, Stuart C. ;
Janssens, Harry L. A. ;
Lampertico, Pietro ;
Lau, Daryl ;
Bornstein, Jeffrey D. ;
Schall, Raul E. Aguilar ;
Dinh, Phillip ;
Yee, Leland J. ;
Martins, Eduardo B. ;
Lim, Seng Gee ;
Loomba, Rohit ;
Petersen, Joerg ;
Buti, Maria ;
Marcellin, Patrick .
JOURNAL OF HEPATOLOGY, 2016, 64 (04) :773-780
[5]   Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT [J].
Kumar, Manoj ;
Sarin, Shiv K. ;
Hissar, Syed ;
Pande, Chandana ;
Sakhuja, Puja ;
Sharma, Barjesh Chander ;
Chauhan, Ranjit ;
Bose, Sujoy .
GASTROENTEROLOGY, 2008, 134 (05) :1376-1384
[6]   The natural history and evaluation of standard treatment of chronic hepatitis B: A critical treatment criteria and end points [J].
Lai, Ching-Lung ;
Yuen, Man-Fung .
ANNALS OF INTERNAL MEDICINE, 2007, 147 (01) :58-61
[7]   Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update [J].
Liaw, Yun-Fan ;
Kao, Jia-Horng ;
Piratvisuth, Teerha ;
Chan, Henry Lik Yuen ;
Chien, Rong-Nan ;
Liu, Chun-Jen ;
Gane, Ed ;
Locarnini, Stephen ;
Lim, Seng-Gee ;
Han, Kwang-Hyub ;
Amarapurkar, Deepak ;
Cooksley, Graham ;
Jafri, Wasim ;
Mohamed, Rosmawati ;
Hou, Jin-Lin ;
Chuang, Wan-Long ;
Lesmana, Laurentius A. ;
Sollano, Jose D. ;
Suh, Dong-Jin ;
Omata, Masao .
HEPATOLOGY INTERNATIONAL, 2012, 6 (03) :531-561
[8]   Chronic Hepatitis B: Update 2009 [J].
Lok, Anna S. F. ;
McMahon, Brian J. .
HEPATOLOGY, 2009, 50 (03) :661-662
[9]   ACUTE EXACERBATIONS IN CHINESE PATIENTS WITH CHRONIC HEPATITIS-B VIRUS (HBV) INFECTION - INCIDENCE, PREDISPOSING FACTORS AND ETIOLOGY [J].
LOK, ASF ;
LAI, CL .
JOURNAL OF HEPATOLOGY, 1990, 10 (01) :29-34
[10]   The accuracy of the FIB-4 index for the diagnosis of mild fibrosis in chronic hepatitis B [J].
Mallet, V. ;
Dhalluin-Venier, V. ;
Roussin, C. ;
Bourliere, M. ;
Pettinelli, M. E. ;
Giry, C. ;
Vallet-Pichard, A. ;
Fontaine, H. ;
Pol, S. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009, 29 (04) :409-415